Acne & Rosacea Market | Size | Analysis | Share | Growth Drivers | Outlook | US Forecast to 2022

reportsandreports

MarketReportsOnline.com the exclusive leading provider of market research reports published research report on “US Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)”.

The report “U.S. Acne & Rosacea Market: Industry Analysis & Outlook (2018-2022)” provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. market. The report profiles the key players of the market including Bausch Health Companies, Allergan, Foamix Pharmaceuticals and Sol-Gel Technologies.

Acne and Rosacea are the most common dermatological disorders affecting people in the United States. Acne is a chronic skin disorder in which the hair follicles become blocked and/or inflamed, which is most prevalent among teenagers. However, some people may suffer from acne well into their 30s and 40s even. Acne can occur in forms ranging from comedones to cystic lesions, depending upon severity.

Get Free Sample Copy of This Report @ http://www.marketreportsonline.com/contacts/requestsample.php?name=781526.

Rosacea is a common skin condition that causes redness and visible blood vessels on the nose, cheeks, and forehead. Rosacea can occur to anyone. But it is most commonly affects adults over age 30, particularly women with fair skin. The condition of rosacea is increasingly widespread in the U.S. and affecting approximately 16 million population in the country.

Topical drugs currently dominate both markets in the U.S. Systemic medications such as oral antibiotics, hormonal agents or other drugs are also used for the treatment of acne and rosacea. The ongoing development of new drugs is expected to witness an extraordinary growth rate due to higher efficacy, convenient dosing and fewer side effects.

The increase in emotional burden due to these skin conditions is a key factor driving the growth of the market. Growing awareness regarding rosacea and acne treatment options has significantly driven the market in the U.S. Rising purchasing power and mounting healthcare expenditure has also fuelled the growth of the market in the region. Despite being common skin disorders, advancement in treatment has been limited over the past years exhibiting a great opportunity of growth in the future. The companies are developing new treatment options, in which, most products are in late-stage indicating an optimistic future for the market.

Purchase a copy of this “U.S. Acne & Rosacea Market” research report @ http://www.marketreportsonline.com/contacts/purchase.php?name=781526.

Few Points from List of Tables:

 

Acne Treatment Continuum

Limitations of Commonly Used Acne Treatments

The U.S. Rosacea Market Revenue and Prescription by Drug Type (2017)

The U.S. Rosacea Drug Revenue and Prescription by Brand (2017)

Key Players – Revenue & Market Cap Comparison (2017)

Global Acne Market- Drug Comparison by Company (2017)

Global Late Stage Acne Market- Drug Comparison by Company (2017)

Global Mid Stage Acne Market- Drug Comparison by Company (2017)

Global Rosacea Market- Drug Comparison by Company (2017)

Foamix Pharmaceuticals Product Pipeline (2017)

Sol Gel Technologies Ltd. Product Pipeline (2017)

Browse all latest healthcare market research reports @ http://www.marketreportsonline.com/cat/healthcare-market-research.html.

About Us:

Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.

Connect us @ [email protected]rtsonline.com with subject line “Market Research Report on US Acne & Rosacea Market “ and your contact details to purchase this report or get your questions answered. OR Call Us @ +1 888 391 5441.